Nautilus appoints Karen Akinsanya to Nominating and Governance Committee

Nautilus Biotechnology, Inc.

Appointment effective October 27, 2022; committee now includes McIlwain (Chair), Pande, and Akinsanya.
Akinsanya joined the Board in March 2022; committee assignment was previously undetermined.
This amendment updates the original 8-K filed March 31, 2022 regarding Akinsanya's directorship.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.